We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+22.59%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$204B
AUM Growth
+$33.9B
Cap. Flow
+$1.02B
Cap. Flow %
0.5%
Top 10 Hldgs %
17%
Holding
3,435
New
201
Increased
1,862
Reduced
1,124
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 19.78%
2 Healthcare 12.43%
3 Financials 11.93%
4 Consumer Discretionary 9.96%
5 Industrials 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WHWK
3301
Whitehawk Therapeutics
WHWK
$190M
$17K ﹤0.01%
856
TPHS
3302
DELISTED
Trinity Place Holdings Inc.com
TPHS
$17K ﹤0.01%
12,207
CVIA
3303
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$17K ﹤0.01%
116,313
-72,406
-38% -$39.6K
LEE icon
3304
Lee Enterprises
LEE
$172M
$16K ﹤0.01%
1,545
-11,121
-88% -$106K
AMPY icon
3305
Amplify Energy
AMPY
$161M
$15K ﹤0.01%
11,998
-27,233
-69% -$32.6K
HDSN
3306
Hudson Technologies
HDSN
$254M
$15K ﹤0.01%
14,328
NEOS
3307
DELISTED
Neos Therapeutics, Inc
NEOS
$15K ﹤0.01%
21,090
HTGM
3308
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$14K ﹤0.01%
104
DXLG icon
3309
Destination XL Group
DXLG
$31.2M
$12K ﹤0.01%
18,114
EYPT icon
3310
EyePoint Inc
EYPT
$1.03B
$12K ﹤0.01%
1,460
-12,814
-90% -$110K
MMAT
3311
DELISTED
Meta Materials Inc. Common Stock
MMAT
$12K ﹤0.01%
165
SER icon
3312
Serina Therapeutics
SER
$30M
$11K ﹤0.01%
303
-1,257
-81% -$37K
STCN
3313
DELISTED
Steel Connect, Inc. Common Stock
STCN
$11K ﹤0.01%
1,960
RIBT
3314
DELISTED
RiceBran Technologies
RIBT
$11K ﹤0.01%
1,244
DMK
3315
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$9K ﹤0.01%
236
CARM
3316
DELISTED
Carisma Therapeutics
CARM
$8K ﹤0.01%
550
HCR
3317
DELISTED
Hi-Crush Inc. Common Stock
HCR
$8K ﹤0.01%
48,197
RTW
3318
DELISTED
RTW Retailwinds, Inc.
RTW
$4K ﹤0.01%
15,491
-67,220
-81% -$19.8K
ACNT icon
3319
Ascent Industries
ACNT
$140M
-19,228
Closed -$168K
AIRG icon
3320
Airgain
AIRG
$73.4M
-22,662
Closed -$168K
ALDX icon
3321
Aldeyra Therapeutics
ALDX
$92.9M
-52,683
Closed -$131K
ALOT icon
3322
AstroNova
ALOT
$225M
-16,119
Closed -$126K
AOA icon
3323
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.19B
-9,289
Closed -$441K
AOR icon
3324
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.66B
-11,425
Closed -$473K
BSET icon
3325
Bassett Furniture
BSET
$164M
-25,946
Closed -$142K

Similar funds

Charles Schwab's Q2 2020 Portfolio in Review

As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
  • Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
  • Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
  • Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
  • Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
  • Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
  • Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.

Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.